272 related articles for article (PubMed ID: 32339038)
1. ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.
Bainey KR; Bates ER; Armstrong PW
Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006834. PubMed ID: 32339038
[No Abstract] [Full Text] [Related]
2. Why Fibrinolytic Therapy for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic Is Not Your New Best Friend.
Kirtane AJ; Bangalore S
Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006885. PubMed ID: 32339025
[No Abstract] [Full Text] [Related]
3. Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?
Daniels MJ; Cohen MG; Bavry AA; Kumbhani DJ
Circulation; 2020 Jun; 141(24):1948-1950. PubMed ID: 32282225
[No Abstract] [Full Text] [Related]
4. No Reduction of ST-segment Elevation Myocardial Infarction Admission in Taiwan During Coronavirus Pandemic.
Li YH; Huang WC; Hwang JJ;
Am J Cardiol; 2020 Sep; 131():133-134. PubMed ID: 32713656
[No Abstract] [Full Text] [Related]
5. Effect of the COVID-19 Pandemic on ST-Segment-Elevation Myocardial Infarction Presentations and In-Hospital Outcomes.
Wilson SJ; Connolly MJ; Elghamry Z; Cosgrove C; Firoozi S; Lim P; Sharma R; Spratt JC
Circ Cardiovasc Interv; 2020 Jul; 13(7):e009438. PubMed ID: 32600109
[No Abstract] [Full Text] [Related]
6. Primary Percutaneous Coronary Intervention or Fibrinolytic Therapy in COVID 19 Patients Presenting With ST-Segment Elevation Myocardial Infarction.
Sudhakar D; Jneid H; Lakkis N; Kayani WT
Am J Cardiol; 2020 Nov; 134():158. PubMed ID: 32841613
[No Abstract] [Full Text] [Related]
7. A treatment strategy for acute myocardial infarction and personal protection for medical staff during the COVID-19 epidemic: the Chinese experience.
Han Y
Eur Heart J; 2020 Jun; 41(23):2148-2149. PubMed ID: 32338764
[No Abstract] [Full Text] [Related]
8. Standards of Care in Crisis: ST-Segment-Elevation Myocardial Infarction Management in COVID-19.
Mihatov N; Kirtane AJ
Circ Cardiovasc Interv; 2020 Nov; 13(11):e010143. PubMed ID: 33167704
[No Abstract] [Full Text] [Related]
9. Impact of COVID-19 on reperfusion strategies for acute coronary syndromes.
Torres-Escobar G; González-Pacheco H; Cruz JLB; Arias-Mendoza A; Araiza-Garaygordobil D
Arch Cardiol Mex; 2020; 90(Supl):62-66. PubMed ID: 32523136
[TBL] [Abstract][Full Text] [Related]
10. Where have the ST-segment elevation myocardial infarctions gone during COVID-19 lockdown?
Rangé G; Hakim R; Motreff P
Eur Heart J Qual Care Clin Outcomes; 2020 Jul; 6(3):223-224. PubMed ID: 32348457
[No Abstract] [Full Text] [Related]
11. Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic.
Yerasi C; Case BC; Forrestal BJ; Chezar-Azerrad C; Hashim H; Ben-Dor I; Satler LF; Mintz GS; Waksman R
Cardiovasc Revasc Med; 2020 Aug; 21(8):1024-1029. PubMed ID: 32471712
[TBL] [Abstract][Full Text] [Related]
12. Assessment of ST-Segment Elevation Myocardial Infarction Volume Trends During The COVID-19 Pandemic.
Lotfi AS; Capatina A; Kugelmass AD
Am J Cardiol; 2020 Sep; 131():132-133. PubMed ID: 32732009
[No Abstract] [Full Text] [Related]
13. The Obstacle Course of Reperfusion for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic.
Roffi M; Guagliumi G; Ibanez B
Circulation; 2020 Jun; 141(24):1951-1953. PubMed ID: 32315205
[No Abstract] [Full Text] [Related]
14. ST-segment elevation myocardial infarction in times of COVID-19: back to the last century? A call for attention.
Gadella A; Sastre MÁ; Maicas C; Rodríguez-Padial L; Arias MÁ
Rev Esp Cardiol (Engl Ed); 2020 Jul; 73(7):582-583. PubMed ID: 32381326
[No Abstract] [Full Text] [Related]
15. ST-segment Elevation, Myocardial Injury, and Suspected or Confirmed COVID-19 Patients: Diagnostic and Treatment Uncertainties.
Bennett CE; Anavekar NS; Gulati R; Singh M; Kane GC; Sandoval Y; Foley TA; Jaffe AS; Sandhu GS; Bell MR; Askew JW
Mayo Clin Proc; 2020 Jun; 95(6):1107-1111. PubMed ID: 32414550
[No Abstract] [Full Text] [Related]
16. Decrease in ST-segment elevation myocardial infarction admissions in Catalonia during the COVID-19 pandemic.
Romaguera R; Ribera A; Güell-Viaplana F; Tomás-Querol C; Muñoz-Camacho JF; Agudelo V;
Rev Esp Cardiol (Engl Ed); 2020 Sep; 73(9):778-780. PubMed ID: 32565077
[No Abstract] [Full Text] [Related]
17. Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era.
Elbadawi A; Mahtta D; Elgendy IY; Saad M; Krittanawong C; Hira RS; Omer M; Ogunbayo GO; Garratt K; Rao SV; Jneid H
JACC Cardiovasc Interv; 2020 Oct; 13(19):2312-2314. PubMed ID: 33032721
[No Abstract] [Full Text] [Related]
18. COVID-19-Specific Strategies for the Treatment of ST-Segment Elevation Myocardial Infarction in China.
Ranard LS; Parikh SA; Kirtane AJ
J Am Coll Cardiol; 2020 Sep; 76(11):1325-1327. PubMed ID: 32807587
[TBL] [Abstract][Full Text] [Related]
19. High thrombus burden despite thrombolytic therapy in ST-elevation myocardial infarction in a patient with COVID-19.
Setia G; Tyler J; Kwan A; Faguet J; Sharma S; Singh S; Azarbal B; Tompkins R; Chinchilla D; Ghandehari S
Rev Cardiovasc Med; 2020 Jun; 21(2):289-295. PubMed ID: 32706216
[TBL] [Abstract][Full Text] [Related]
20. [Analysis on the efficacy and safety of fibrinolytic therapy in patients with acute ST-segment elevation myocardial infarction during the COVID-19 epidemic].
Wei F; Shuai XX; Chen ZJ; Cao GL; Wang L; Qiu T; Hu T; Wu L; Zhang Q; Huang HX; Zhang YW; Zhu L; Cheng X
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jun; 48(6):472-476. PubMed ID: 32842256
[No Abstract] [Full Text] [Related]
[Next] [New Search]